Skip to content
Clinical Trials – home

Daptomycin: A Comprehensive Guide for Patients

12 / 13
trials open to patients / all trials
6+
Countries

In short

Daptomycin is an antibiotic used to treat various bacterial infections, particularly those caused by Gram-positive organisms. This article examines several clinical trials investigating the use of daptomycin in different patient populations and conditions, including prosthetic joint infections, endocarditis, and meningitis. These studies aim to evaluate the drug's efficacy, safety, and pharmacokinetics in various clinical settings.

What is Daptomycin?

Daptomycin, also known by its brand name Cubicin, is an antibiotic medication used to treat various bacterial infections. It belongs to a class of drugs called cyclic lipopeptides, which are designed to combat difficult-to-treat bacterial infections. Daptomycin is particularly effective against Gram-positive bacteria, including strains that have become resistant to other antibiotics like methicillin, vancomycin, or linezolid.

How Daptomycin Works

Daptomycin works differently from many other antibiotics. It binds to the membrane of Gram-positive bacteria and causes rapid depolarization of the membrane potential. This leads to bacterial cell death without causing the bacteria to break open (a process called lysis). This unique mechanism is important because it doesn't release harmful bacterial components into the body, which can trigger excessive inflammation and potentially cause more damage.

Conditions Treated with Daptomycin

Daptomycin is used to treat a variety of bacterial infections, including:

  • Complicated skin and soft tissue infections: These are infections of the skin and underlying tissues that are severe or difficult to treat.
  • Bloodstream infections (bacteremia): This occurs when bacteria enter the bloodstream, potentially leading to serious complications.
  • Infective endocarditis: An infection of the inner lining of the heart chambers and valves.
  • Prosthetic joint infections: Infections that occur around artificial joints, such as hip, knee, or shoulder replacements.
  • Bacterial meningitis: An infection of the protective membranes covering the brain and spinal cord.

How Daptomycin is Administered

Daptomycin is typically given as an intravenous (IV) infusion, meaning it's delivered directly into a vein. The medication is usually administered once daily, with the infusion lasting about 30 minutes. In some cases, it may be given as a subcutaneous injection (under the skin) if IV access is difficult.

Dosage Information

The dosage of daptomycin can vary depending on several factors, including the type and severity of the infection, the patient's age, weight, and kidney function. Some common dosages include:

  • For adults: 4-6 mg/kg once daily for skin infections, and 6-8 mg/kg once daily for more serious infections like bacteremia or endocarditis.
  • For children: Dosages are typically weight-based and can range from 6-10 mg/kg once daily, depending on the child's age.

Use in Special Populations

Daptomycin has been studied in various special populations:

  • Patients with kidney disease: Daptomycin can be used in patients undergoing hemodialysis or peritoneal dialysis, but dosage adjustments may be necessary.
  • Children: Studies have been conducted to determine appropriate dosing and safety in pediatric patients.
  • Surgical patients: Daptomycin has been investigated as a potential preventive antibiotic for patients undergoing heart surgery.

Potential Side Effects

Like all medications, daptomycin can cause side effects. Some potential side effects include:

  • Muscle effects: Daptomycin can cause muscle pain or weakness. Your doctor may monitor your blood levels of an enzyme called creatine phosphokinase (CPK) to check for muscle damage.
  • Kidney effects: In some cases, daptomycin may affect kidney function.
  • Local reactions: If given as a subcutaneous injection, there may be local reactions like pain, redness, or swelling at the injection site.

Ongoing Research and Future Applications

Research on daptomycin is ongoing, with studies exploring its use in various conditions and populations. Some areas of current research include:

  • Use in pediatric patients with bacterial meningitis.
  • Combination therapy with other antibiotics for difficult-to-treat infections.
  • Alternative routes of administration, such as subcutaneous injections.
  • Use as a preventive antibiotic in certain surgical procedures.

These ongoing studies aim to expand our understanding of daptomycin's effectiveness and safety in various clinical scenarios, potentially leading to new applications and improved treatment strategies for bacterial infections.

Questions people often ask

Conditions where Daptomycin is being studied

Each condition opens its own overview and trial list

Trials with Daptomycin

Recruiting trials first

See all 13 →
Quick filters
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).